Cite
HARVARD Citation
Ellingson, B. et al. (2021). Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma. Neuro-oncology advances. 3 (1), p. . [Online].